loader
Please Wait
Applying Filters...

Octavius Fenofibrate Octavius Fenofibrate

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Looking for Pharmaceutical Excipients offered by Nomisma Healthcare? Find Tox21_300151 to address your drug delivery challenges on PharmaCompass.

    Product
    Nippon provides high-performance, high-value-added cosmetic, pharmaceutical, and industrial raw materials.
    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
    Previous
    Next
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Nomisma Healthcare (2)

    filter

    01 Tablet (2)

    filter

    01 India (2)

    Close
    4
    refresh Reset Filter
    refreshReset Filter
    Learn More #LearnMore
    price-trend Ask Us

    Nomisma Healthcare

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      PLLA-PEG

      PDF Supplier PDF
      URL Supplier Web Content
      LM Application #LearnMore

      Applications:

      PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

      Ingredient(s): Poly L Lactide, Polyethylene Glycol Excipient

      Dosage Form: Tablet

      Category: Controlled & Modified Release

      Route of Administration (Grade): Oral, Parenteral
      Pharmacopoeia Reference: NA

      Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Nomisma Healthcare

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag India
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        PLGA-PEG

        PDF Supplier PDF
        URL Supplier Web Content
        LM Application #LearnMore

        Applications:

        PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

        Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

        Dosage Form: Tablet

        Category: Controlled & Modified Release

        Route of Administration (Grade): Oral, Parenteral
        Pharmacopoeia Reference: NA

        Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Post Enquiry
        POST ENQUIRY